Marc P. Baggelaar

Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity

Marjolein Soethoudt, Uwe Grether, Jürgen Fingerle et al. · Nature Communications · 2017 · 345 citations · Full text

Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474

Annelot C. M. van Esbroeck, Antonius P. A. Janssen, Armand B. Cognetta et al. · Science · 2017 · 321 citations · Full text

Rapid and profound rewiring of brain lipid signaling networks by acute diacylglycerol lipase inhibition

Daisuke Ogasawara, Hui Deng, Andreu Viader et al. · Proceedings of the National Academy of Sciences · 2015 · 158 citations · Full text

Diacylglycerol Lipases, Molecular Physiology, Signal Transduction +15

The novel, orally available and peripherally restricted selective cannabinoid CB₂ receptor agonist LEI‐101 prevents cisplatin‐induced nephrotoxicity

Partha Mukhopadhyay, Marc P. Baggelaar, Katalin Erdélyi et al. · British Journal of Pharmacology · 2015 · 82 citations · Full text

Development of an Activity‐Based Probe and In Silico Design Reveal Highly Selective Inhibitors for Diacylglycerol Lipase‐α in Brain

Marc P. Baggelaar, Freek J. Janssen, Annelot C. M. van Esbroeck et al. · Angewandte Chemie International Edition · 2013 · 75 citations

Systems Pharmacology, Inhibitory Activity, Proteinlipid Interaction +15